These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34791217)

  • 21. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variants.
    Tio M; Wen R; Lim YL; Zukifli ZHB; Xie S; Ho P; Zhou Z; Koh TW; Zhao Y; Tan EK
    Hum Mutat; 2017 Aug; 38(8):978-987. PubMed ID: 28432706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy.
    Rubino E; Zhang M; Mongini T; Boschi S; Vercelli L; Vacca A; Govone F; Gai A; Giordana MT; Grinberg M; Rogaeva E; Rainero I
    Neurobiol Aging; 2018 Jun; 66():181.e1-181.e2. PubMed ID: 29519717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.
    Good CH; Hoffman AF; Hoffer BJ; Chefer VI; Shippenberg TS; Bäckman CM; Larsson NG; Olson L; Gellhaar S; Galter D; Lupica CR
    FASEB J; 2011 Apr; 25(4):1333-44. PubMed ID: 21233488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
    Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of CHCHD2 Stability Coordinates with C1QBP/CHCHD2/CHCHD10 Complex Impairment to Mediate PD-Linked Mitochondrial Dysfunction.
    Ren YL; Jiang Z; Wang JY; He Q; Li SX; Gu XJ; Qi YR; Zhang M; Yang WJ; Cao B; Li JY; Wang Y; Chen YP
    Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38453793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired motor coordination in Pitx3 overexpression mice.
    Kim H; Quan X; Seong Y; Kim J
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1211-8. PubMed ID: 24680684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease.
    Liu Z; Guo J; Li K; Qin L; Kang J; Shu L; Zhang Y; Wei Y; Yang N; Luo Y; Sun Q; Xu Q; Yan X; Tang B
    Neurobiol Aging; 2015 Nov; 36(11):3117.e7-3117.e8. PubMed ID: 26343503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice.
    Sato S; Noda S; Torii S; Amo T; Ikeda A; Funayama M; Yamaguchi J; Fukuda T; Kondo H; Tada N; Arakawa S; Watanabe M; Uchiyama Y; Shimizu S; Hattori N
    Hum Mol Genet; 2021 Apr; 30(6):443-453. PubMed ID: 33631794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of Dopaminergic Functions in Drosophila.
    Inoshita T; Takemoto D; Imai Y
    Methods Mol Biol; 2021; 2322():185-193. PubMed ID: 34043204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
    Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
    EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues.
    Chen C; Vincent AE; Blain AP; Smith AL; Turnbull DM; Reeve AK
    Neurobiol Dis; 2020 Feb; 134():104631. PubMed ID: 31689514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PINK1-Parkin signaling in Parkinson's disease: Lessons from Drosophila.
    Imai Y
    Neurosci Res; 2020 Oct; 159():40-46. PubMed ID: 32035987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
    Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
    Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease.
    Lai JH; Chen KY; Wu JC; Olson L; Brené S; Huang CZ; Chen YH; Kang SJ; Ma KH; Hoffer BJ; Hsieh TH; Chiang YH
    Brain Res; 2019 Oct; 1720():146301. PubMed ID: 31226324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: a genome-wide linkage and sequencing study.
    Funayama M; Ohe K; Amo T; Furuya N; Yamaguchi J; Saiki S; Li Y; Ogaki K; Ando M; Yoshino H; Tomiyama H; Nishioka K; Hasegawa K; Saiki H; Satake W; Mogushi K; Sasaki R; Kokubo Y; Kuzuhara S; Toda T; Mizuno Y; Uchiyama Y; Ohno K; Hattori N
    Lancet Neurol; 2015 Mar; 14(3):274-82. PubMed ID: 25662902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10-what distinguishes the two?
    Ikeda A; Imai Y; Hattori N
    Front Cell Dev Biol; 2022; 10():996061. PubMed ID: 36158221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.